GIVAX

GIVAX leverages clinically proven live-attenuated rotavirus vaccine as a delivery vector for norovirus antigens to create a dually protective vaccine.

Domain
Healthcare
Status
Current Private Investment
Stage of Initial Investment
NewCo
Initial Investment Year
2021
GIVAX Hover Image